KLOW 80 mg peptide blend

Buy KLOW peptide blend 80 mg for laboratory research. Each boxed 3 mL vial contains lyophilized powder with four labeled components: GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg and KPV 10 mg.

• GHK-Cu: 50 mg per vial
• TB-500: 10 mg per vial
• BPC-157: 10 mg per vial
• KPV: 10 mg per vial
• Total blend: 80 mg per vial

The GHK-Cu component is the peptide-copper complex identified by CAS 89030-95-5. The TB-500 component is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.

KLOW composition and product choice

Compared with the GLOW 70 mg blend, KLOW includes an additional 10 mg of KPV. The labeled amounts of the other three ingredients remain the same. The extra component changes the formulation; it does not establish a stronger or more effective product.

The 50 mg GHK-Cu amount describes the complete peptide-copper complex, including copper. It is not 50 mg of copper alone or copper-free GHK. A premixed vial also fixes the ingredient proportions. If a study needs a separate copper-peptide control, the GHK-Cu product is a different presentation to consider.

What the component studies show

Maquart and colleagues reported increased collagen synthesis in fibroblast cultures exposed to GHK-Cu, independently of changes in cell number. That result describes the copper-peptide complex in a cell model.

BPC-157 experiments examined migration in rat-derived tendon cells. TB-500 analytical research identified an acetylated seven-residue fragment in a different preparation. That study does not characterize this blend’s full-length TB-500 component.

Dalmasso and colleagues examined KPV transport through PepT1 and inflammatory signaling in intestinal and immune-cell models. Their work did not test KLOW.

The cited studies used individual materials and different experimental systems. They do not demonstrate synergy or predict the performance of this four-component mixture. Compare the complete formulation with appropriate component controls when interpreting results.

Certificate of analysis and product documentation

Open COA & Documents to review the available batch records. Match the lot and formulation, then check which components were identified and whether their amounts were measured separately. Purity, identity and component content answer different questions; one percentage cannot stand in for all three.

Use the supplied chemical forms for molecular calculations and the mixture’s documentation for handling and storage. The 3 mL figure describes vial capacity, not liquid supplied or a preparation volume.